|
Gender(male)
|
2.83(0.75–10.69)
|
0.124
| | |
|
Age (>= 65 years)
|
0.5(0.17–1.5)
|
0.219
| | |
|
Hepatitis
|
|
HBV vs NBNC
|
1.62(0.53–4.98)
|
0.396
| | |
|
HCV vs NBNC
|
2.2(0.11–42.74)
|
0.602
| | |
|
NAFLD (yes)
|
2.21(0.36–13.67)
|
0.395
| | |
|
Cirrhosis (yes)
|
1(0.49–2.05)
|
0.993
| | |
|
Resection type (major resection)
|
1.82(0.85–3.91)
|
0.122
| | |
|
Lymph node dissection (yes)
|
1.72(0.65–4.56)
|
0.278
| | |
|
Tumor number (multiple)
|
2.65(1.19–5.89)
|
0.017
|
1.06(0.36–3.14)
|
0.920
|
|
Tumor size (>= 5 cm)
|
1.94(0.95–3.94)
|
0.069
| | |
|
Tumor capsule (present)
|
0.76(0.37–1.56)
|
0.449
| | |
|
Microvascular invasion (present)
|
3.09(1.45–6.57)
|
0.003
|
3.73(1.43–9.71)
|
0.007
|
|
Macrovascular invasion (present)
|
5.44(1.98–14.96)
|
0.001
|
5.75(1.73–19.04)
|
0.004
|
|
Satellite nodules (present)
|
3.54(1.68–7.46)
|
< 0.001
|
2.5(0.98–6.4)
|
0.056
|
|
Edmondson-Steiner classification(III/IV)
|
0.66(0.26–1.68)
|
0.387
| | |
|
RBC(>= 4 × 10^12/L)
|
0.8(0.22–2.88)
|
0.733
| | |
|
Hb(< 120 × g/L)
|
1.97(0.42–9.2)
|
0.387
| | |
|
PLT(< 300 × 10^9/L)
|
0.8(0.25–2.53)
|
0.704
| | |
|
Neutrophil count(>= 5 × 10^9/L)
|
0.57(0.26–1.29)
|
0.181
| | |
|
Lymphocyte count(>= 1.5 × 10^9/L)
|
0.97(0.43–2.18)
|
0.937
| | |
|
NLR(>= 1.6)
|
0.57(0.23–1.43)
|
0.230
| | |
|
AST(>= 40 U/L)
|
1(0.5–2.01)
|
0.991
| | |
|
PT(>= 13 s)
|
1.25(0.4–3.95)
|
0.704
| | |
|
TB(>= 17.1 umol/L)
|
0.83(0.39–1.75)
|
0.618
| | |
|
ALB(< 40 g/L)
|
1.03(0.47–2.23)
|
0.949
| | |
|
GGT(>= 75 U/L)
|
1.76(0.87–3.55)
|
0.116
| | |
|
ALP(>= 78 U/L)
|
4.07(1.79–9.23)
|
< 0.001
|
2.03(0.77–5.33)
|
0.152
|
|
AFP(>= 20 ng/mL)
|
2.77(1.28–5.97)
|
0.009
|
1.97(0.78–4.96)
|
0.152
|
|
CEA(>= 5 ng/mL)
|
0.84(0.29–2.46)
|
0.747
| | |
|
CA19-9(>= 25 U/mL)
|
3.66(1.73–7.73)
|
< 0.001
|
2.48(1–6.13)
|
0.049
|
|
DCP(>= 200 mAU/mL)
|
2.62(1.24–5.57)
|
0.012
|
1.43(0.57–3.58)
|
0.440
|
|
Intraoperative blood loss(>= 200 mL)
|
0.96(0.47–1.94)
|
0.906
| | |
|
Intraoperative blood transfusion (yes)
|
0.82(0.38–1.79)
|
0.622
| | |
